• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • PRODUCT SECTIONS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • VIDEOS

LongueVue Capital, in Partnership with Management, Completes Investment in Zavation Medical Products, LLC

July 26, 2017 By SPINEMarketGroup

New Orleans, Louisiana – July 25, 2017 – LongueVue Capital (“LVC”) is pleased to announce it has partnered with management to acquire Zavation Medical Products (“Zavation” or the “Company”) and provide capital for growth. Zavation is a designer and manufacturer of high quality spinal implants, instruments, and biologics. Zavation expands LVC’s healthcare portfolio and is the second medical device business LVC has partnered within the past 18 months.

Based in Jackson, MS, Zavation designs, engineers, and manufactures a portfolio of spinal hardware covering key areas including thoracolumbar, cervical, interbody fusion, and minimally invasive surgery. Founded in 2010 with its first sale in 2012, Zavation has experienced exceptional growth and created a national network of 100+ distributors across approximately 35 states. The Company has commercialized over 10 product families since inception, with 10 additional novel products expected to launch over the next two years. Zavation operates a 24,000 square foot vertically integrated facility with approximately 50 employees.

“Zavation has demonstrated exceptional growth and is a perfect cornerstone to our expanding healthcare portfolio. This is our fourth healthcare platform investment and our third in the past 18 months,” said Ryan Nagim, Principal and deal lead at LVC. “Furthermore, we believe the Company is at an inflection point and has the opportunity to become a market leader in the spinal implant sector, as management has shown an incredible ability to execute. As such, we look forward to our partnership with Zavation’s management team and driving significant growth, both organically and through acquisitions of unique technologies.”

“Zavation fits well within LVC’s investment strategy,” added Rick Rees, Founder and Managing Partner of LVC. “We love partnering with entrepreneur owned businesses at inflection points that have proven management teams willing to invest meaningfully alongside LVC. The Company’s rapid growth is a testament to management’s ability to capitalize on compelling demographics and other industry tailwinds favoring smaller, more agile, and customer focused OEMs. Lastly, although we are geographically agnostic, it is always great to partner with entrepreneurs in our back yard, the Gulf South. As such, we are incredibly excited to partner with management and welcome Zavation into the LVC family.”

“The management team at Zavation chose LVC due to their entrepreneur-friendly investment approach to value creation and their knowledge and expertise in growing middle market companies at inflection points like ours. With a shared vision and culture, we are confident Zavation will remain focused on its core values of excellent customer service and quality products,” said Jeffrey Johnson, President and CEO of Zavation. “LVC’s financial and operational resources will allow us to introduce new products, meet and exceed distributor and surgeon expectations, expand our market presence, and take market share at an even faster and more deliberate speed. We are excited for our Company, our distributors, our surgeons, and our LVC partners.”

Robert W. Baird & Co.’s healthcare team, led by Robert Andrews and Manish Gupta, served as exclusive financial advisor to LVC on the transaction. Abacus Finance Group, LLC provided the senior debt financing to Zavation Medical Products in support of the transaction. LVC’s legal counsel was provided by McGuireWoods, LLP.

To learn more information about Zavation and its products, visit www.zavation.com

About LongueVue Capital:

LongueVue Capital is a private equity firm focused on making situation-driven, value-oriented equity and debt investments in lower middle market companies (up to $150 million in annual revenue) to support buy-outs, recapitalizations, acquisitions and growth. LVC currently has $425 million under management across two funds. Since its formation in 2001, LVC has made successful investments in a wide variety of industries, including healthcare, business services, transportation and logistics, energy services, and niche manufacturing. LVC is based in New Orleans with additional offices in New York and Salt Lake City. For more information, please visit www.lvcpartners.com.

For inquiries, please contact [email protected] or call 504-293-3600.

(Visited 19 times, 3 visits today)

Filed Under: NEWS Tagged With: 2017, NEWS

Primary Sidebar

PLATINUM SPONSORS

GOLD SPONSORS

MOST POPULAR POSTS

  • BROCHURES
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • Stryker’s Spine Exit: What It Means for…
  • What’s Happening with Globus Medical? Why Has the…
  • Just Reflective, Not Disappointed: Globus Medical’s…
  • (UPDATED 2024): +8 Lumbar Artificial Discs to Know…
  • Stryker’s Spine Business Sale: A Smart Move or a…
  • Why Didn’t Globus Medical’s Stock Rise After…
  • Update:Stay Tuned Next Week! Is Globus Medical the…
  • Globus Medical extends versatility of Advanced…
  • M6 Discontinued: What Are the Alternatives for a…
  • Dispute Over Spinal Implant Royalties Between…
  • Eminent Spine’s 3D Printed Titanium Pedicle Screw…
  • Orthofix Discontinues M6-C™ and M6-L™ Artificial…
  • What Are the Strategic Reasons Behind Globus…
  • (Updated!) 15 Expandable PLIF Cages to Know…!
  • (UPDATED 2024): +108 Stand-Alone Cervical Cages to Know..!
  • Alphatec Today: Where It Stands and Where It’s Heading?
  • Globus Medical Reports First Quarter 2025 Results
  • Has Globus Already Surpassed Medtronic in the Spine…
  • LAST 10 VIDEOS PUBLISHED

    1. POWEHI MEDICAL AG: TANTO® Screw
    2. Syntropiq: Taurus TLIF (Short)
    3. LEM Surgical: Dynamis Surgical Robot
    4. Aegis Spine:PathLoc-TA
    5. NGMedical: MOVE®-C Artificial Disc
    6. B.Braun Aesculap: Ennovate® Cervical MIS
    7. Spineart: PERLA® TL Deformity Solutions
    8. NGMedical: MOVE®-C
    9. Normmed Medical: ALIF Peek Cage
    10. PainTEQ: LinQ Sacroiliac

    Recent Comments

    • Sandy on Just Reflective, Not Disappointed: Globus Medical’s Bittersweet Q1 2025
    • SPINEMarketGroup on M6 Discontinued: What Are the Alternatives for a Cervical Artificial Disc?
    • Sergio López-Fombona on M6 Discontinued: What Are the Alternatives for a Cervical Artificial Disc?
    • Drew on Has Globus Already Surpassed Medtronic in the Spine Market? Can J&J Find Its Way Back to the Top?
    • Ahmed Hassan El-Naggary on Has Globus Already Surpassed Medtronic in the Spine Market? Can J&J Find Its Way Back to the Top?
    • Anonymous on Has Globus Already Surpassed Medtronic in the Spine Market? Can J&J Find Its Way Back to the Top?
    • Email
    • Twitter
    • YouTube

    Subscribe to Our Newsletter!

    Check your inbox or spam folder to confirm your subscription.

    Footer

    • Email
    • Twitter
    • YouTube

    Contact us:

    [email protected] [email protected]

    PRIVATE POLICY

    • Legal Advice
    • Embed Link
    • VIDEOS

    Copyright © 2025 · SPINEMarketGroup

    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
    View preferences
    {title} {title} {title}